VIMTALABS.NS

Vimta Labs Limited · Healthcare · Diagnostics & Research

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$8.05B

PE Ratio

14.629371899499187

EV to Ebitda

—

Earnings Yield

565506193.05%

Revenue (TTM)

$37.6M

Net Income (TTM)

$5.7M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

14.90%

Profit Margin

15.22%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

0.00%

All fundamentals

Core6 fields›

Market Cap$8.05B

Revenue TTM$37.6M

Shares Outstanding22.1M

Float6462286

Insider Ownership67.43%

Institutional Ownership1.91%

Growth Estimates3 fields›

Revenue Growth (Quarterly YoY)14.90%

EPS Growth (Quarterly YoY)-12.80%

EPS Growth Est Quarterly0

Operations14 fields›

Revenue TTM$37.6M

Gross Margin TTM77.67%

Gross Margin (Quarterly)75.70%

Operating Margin TTM20.94%

Operating Margin (Quarterly)17.59%

Profit Margin TTM15.22%

Profit Margin (Quarterly)13.23%

Net Income TTM$5.7M

EPS TTM20.36

EBIT Margin TTM28.50%

EBITDA TTM$10.7M

Capex % of Revenue TTM17.53%

Capital Expenditures$6.6M

FCF % of Revenue (Quarterly)6.54%

Efficiency1 fields›

ROA13.27%

Valuation6 fields›

P/E (TTM)14.629371899499187

P/E Forward0

EV/Revenues (TTM)3.1141

Earnings Yield565506193.05%

Dividend Yield0.00%

Payout Ratio9.53%

Liquidity3 fields›

Cash Per Share5.451673764466062

Current Ratio2.6043896207250414

Interest Expense$29.7M

Yields3 fields›

Dividend Yield0.00%

Payout Ratio9.53%

Earnings Yield565506193.05%